SI1945631T1 - aminopirazol pirimidin derivati za uporabo kot inhibitorji tirozin kinaze pri zdravljenju karcinoma - Google Patents

aminopirazol pirimidin derivati za uporabo kot inhibitorji tirozin kinaze pri zdravljenju karcinoma

Info

Publication number
SI1945631T1
SI1945631T1 SI200631446T SI200631446T SI1945631T1 SI 1945631 T1 SI1945631 T1 SI 1945631T1 SI 200631446 T SI200631446 T SI 200631446T SI 200631446 T SI200631446 T SI 200631446T SI 1945631 T1 SI1945631 T1 SI 1945631T1
Authority
SI
Slovenia
Prior art keywords
aminopyrazole
cancer
treatment
tyrosine kinase
kinase inhibitors
Prior art date
Application number
SI200631446T
Other languages
English (en)
Inventor
Xiaomei Feng
Huiping Guan
Ying Kan
Stephanos Ioannidis
Bo Peng
Mei Su
Bin Wang
Tao Wang
Hai-Jun Zhang
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority claimed from PCT/GB2006/003978 external-priority patent/WO2007049041A1/en
Publication of SI1945631T1 publication Critical patent/SI1945631T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200631446T 2005-10-28 2006-10-26 aminopirazol pirimidin derivati za uporabo kot inhibitorji tirozin kinaze pri zdravljenju karcinoma SI1945631T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73129905P 2005-10-28 2005-10-28
US80306106P 2006-05-24 2006-05-24
PCT/GB2006/003978 WO2007049041A1 (en) 2005-10-28 2006-10-26 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
EP06794902A EP1945631B8 (en) 2005-10-28 2006-10-26 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer

Publications (1)

Publication Number Publication Date
SI1945631T1 true SI1945631T1 (sl) 2012-11-30

Family

ID=40247950

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631446T SI1945631T1 (sl) 2005-10-28 2006-10-26 aminopirazol pirimidin derivati za uporabo kot inhibitorji tirozin kinaze pri zdravljenju karcinoma

Country Status (4)

Country Link
CN (1) CN101346371B (sl)
SI (1) SI1945631T1 (sl)
UA (1) UA95260C2 (sl)
ZA (1) ZA200803582B (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2754659A4 (en) 2011-09-05 2015-08-26 Zhejiang Hisun Pharm Co Ltd 4-SUBSTITUTED- (3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO) -PYRIMIDINES DERIVATIVES HAVING PROTEIN KINASE INHIBITION ACTIVITY AND USE THEREOF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY141220A (en) * 2003-11-17 2010-03-31 Astrazeneca Ab Pyrazole derivatives as inhibitors of receptor tyrosine kinases

Also Published As

Publication number Publication date
UA95260C2 (ru) 2011-07-25
CN101346371B (zh) 2012-11-14
CN101346371A (zh) 2009-01-14
ZA200803582B (en) 2009-02-25

Similar Documents

Publication Publication Date Title
IL190935A0 (en) 4-(3-aminopyrazole)pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
IL186845A0 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
IL174989A0 (en) 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
IL197231A0 (en) Pyrimidines derivatives and their use as kinase inhibitors
SG153875A1 (en) Pyrimidine urea derivatives as kinase inhibitors
IL195152A0 (en) Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
IL174258A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
HK1091480A1 (en) Quinazoline derivatives as tyrosine kinase inhibitors
ZA200606152B (en) 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
ZA200709000B (en) Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
IL173200A0 (en) Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors
IL207224A0 (en) Pyrrolo [2,3-d] pyrimidines and use thereof as tyrosine kinase inhibitors
PL2188289T3 (pl) (7H-pirolo[2,3-D]pirymidyn-4-ylo)-piperazyny jako inhibitory kinaz do leczenia nowotworów i zapalenia
IL187895A0 (en) Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
IL184997A0 (en) Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis
IL185791A0 (en) Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease
IL184798A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
HK1120793A1 (en) 4- (ih-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
ZA200608998B (en) Imidazole derivatives as tyrosine kinase inhibitors
EP1951252A4 (en) INHIBITORS OF TYROSINE KINASES
ZA200902730B (en) Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
ZA200704735B (en) Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis
ZA200803582B (en) 4-(3-Aminopyrazole) Pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
ZA200603037B (en) 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
ZA200710136B (en) Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met